Flow cytometric immunophenotypic assessment of T-cell clonality by V β repertoire analysis: Detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy

American Journal of Clinical Pathology

Volumn 135, Issue 6, 2011, Pages 890-900

  Tembhare, Prashant ^a   Yuan, Constance M ^a   Xi, Liqiang ^a   Morris, John C ^a   Liewehr, David ^b   Venzon, David ^b   Janik, John E ^a   Raffeld, Mark ^a   Stetler Stevenson, Maryalice ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Flow cytometry; T cell clonality; V repertoire

Indexed keywords

T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR VBETA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MALE; MALIGNANT TRANSFORMATION; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HTLV-I INFECTIONS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; YOUNG ADULT;

EID: 79957711804     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPV2D1DDSGJDBW     Document Type: Article

References (26)

1. Rawstron AC, Villamor N, Ritgen M, et al. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia. 2007;21:956-964. (Pubitemid 46672072)
2. Rawstron AC, Kennedy B, Evans PAS, et al. Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood. 2001;98:29-35.
3. Sausville J, Salloum RG, Sorbara L, et al. Minimal residual disease detection in hairy cell leukemia: comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. Am J Clin Pathol. 2003;119:213-217. (Pubitemid 37047876)
4. Stetler-Stevenson MA, Ahmad E, Barnett D, et al. Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2005. CLSI document H43-A2.
5. Shao H, Yuan CM, Xi L, et al. Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma. Am J Clin Pathol. 2010;133:592-601.
6. Al-Mawali A, Gillis D, Lewis I. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. Am J Clin Pathol. 2009;131:16-26.
7. Coustan-Smith E, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. 2000;96:2691-2696.
8. Neale GAM, Coustan-Smith E, Pan Q, et al. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia. 1999;13:1221-1226. (Pubitemid 29396582)
9. Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008;111:5477-5485.
10. β repertoire for clonality assessment in mature TCRαβ T-cell proliferations. Blood. 2001;98:165-173.
11. β repertoire in healthy controls. Cytometry. 2000;40:336-345.
12. Li Y, Braylan R, Al-Quran SZ. Flow-cytometric assessment of T-cell clonality in clinical specimens. Lab Med. 2007;38:477-482. (Pubitemid 47206325)
13. Lima M, Almeida J, Santos AH, et al. Immunophenotypic analysis of the TCR-V repertoire in 98 persistent expansions of CD3+/TCR large granular lymphocytes. Am J Pathol. 2001;159:1861-1868.
14. Ferenczi K, Yawalkar N, Jones D, et al. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy. Arch Dermatol. 2003;139:909-913. (Pubitemid 36898927)
15. β expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques. Am J Clin Pathol. 2004;121:373-383.
16. Beck RC, Stahl S, O'Keefe CL, et al. Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor Vβ antibodies. Am J Clin Pathol. 2003;120:785-794. (Pubitemid 37339688)
17. Jasper GA, Arun I, Venzon D, et al. Variables affecting the quantitation of CD22 in neoplastic B cells [published online ahead of print September 24, 2010]. Cytometry B Clin Cytom. 2011;80:83-90. doi:10.1002/cyto.b.20567.
18. Borowitz M, Bray R, Gascoyne R, et al. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry B Clin Cytom. 1997;30:236-244.
19. McCarthy KP, Sloane JP, Kabarowski JH, et al. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol. 1992;1:173-179.
20. Lawnicki LC, Rubocki RJ, Chan WC, et al. The distribution of gene segments in T-cell receptor gamma gene rearrangements demonstrates the need for multiple primer sets. J Mol Diagn. 2003;5:82-87. (Pubitemid 36559488)
21. Gorczyca W, Weisberger J, Liu Z, et al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry. 2002;50:177-190. (Pubitemid 37517317)
22. Arun I, Wulu JA, Janik JE, et al. Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells. Cytometry B Clin Cytom. 2010;78:169-175.
23. Yokote T, Akioka T, Oka S, et al. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol. 2005;124:199-204. (Pubitemid 41060129)
24. Fitzgerald JE, Ricalton NS, Meyer AC, et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol. 1995;154:3538-3547.
25. Feng B, Jorgensen JL, Hu Y, et al. TCR-Vbeta flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia. J Clin Pathol. 2010;63:141-146.
26. Vissinga C, Charmley P, Concannon P. Influence of coding region polymorphism on the peripheral blood expression of a human TCR Vβ gene. J Immunol. 1994;152:1222-1227. (Pubitemid 24134349)